How should I manage iron deficiency anemia in a 65-year-old female?

Management of Iron Deficiency Anemia in a 65-Year-Old Female

Start with one tablet daily of ferrous sulfate (200 mg), ferrous fumarate (210 mg), or ferrous gluconate (300 mg) taken on an empty stomach, and do not delay treatment while investigating the underlying cause unless colonoscopy is scheduled within days. 1

Initial Treatment Approach

Begin oral iron replacement therapy immediately with 50-100 mg elemental iron once daily (equivalent to one standard ferrous sulfate 200 mg tablet containing 65 mg elemental iron). 1 This dosing strategy is based on evidence showing that higher doses stimulate hepcidin levels, which paradoxically reduces iron absorption by 35-45%, making once-daily dosing as effective as multiple daily doses while minimizing gastrointestinal side effects. 1

Key Treatment Specifications:

• Timing: Take on an empty stomach for optimal absorption 1
• Add vitamin C: Supplement with vitamin C to enhance iron absorption 2
• If not tolerated: Switch to alternate-day dosing (one tablet every other day) rather than changing to a different iron salt, as evidence does not support switching between traditional iron salts 1

Monitoring Protocol

Check hemoglobin at 4 weeks to assess response. 1 This is critical because:

• Absence of at least 10 g/L hemoglobin rise after 2 weeks of daily oral iron predicts treatment failure with 90.1% sensitivity and 79.3% specificity 1
• Early monitoring identifies non-responders who need alternative therapy
• Continue monitoring every 4 weeks until hemoglobin normalizes 1

Duration of Treatment

Continue iron therapy for approximately 3 months after hemoglobin normalization to replenish bone marrow iron stores. 1 After restoration, monitor blood counts every 6 months initially to detect recurrent anemia. 1

When to Switch to Parenteral Iron

Consider intravenous iron if: 1, 2

• Patient cannot tolerate oral iron despite alternate-day dosing
• No hemoglobin response after 4 weeks of adequate oral therapy
• Ferritin levels fail to improve with oral iron
• Conditions affecting absorption (inflammatory bowel disease, celiac disease, post-bariatric surgery)
• Ongoing blood loss with inadequate oral response

Preferred IV formulations: Use high-dose preparations that replace iron deficits in 1-2 infusions (ferric carboxymaltose, ferric derisomaltose) rather than multiple-dose regimens. 2 True anaphylaxis is very rare; most reactions are complement activation-related pseudo-allergy (infusion reactions). 2

Investigation Considerations

At age 65, bidirectional endoscopy (upper endoscopy and colonoscopy) should be pursued to identify gastrointestinal blood loss, which is the most common cause in this age group. 1 However, do not defer iron replacement while awaiting these investigations unless colonoscopy is imminent (within days). 1

Special Considerations for Older Adults:

• Iron deficiency in the elderly is often multifactorial 1
• Carefully weigh risks and benefits of invasive investigations against comorbidities and performance status 1
• Consider malignancy, chronic disease, and nutritional factors 3

Common Pitfalls to Avoid

1. Don't prescribe multiple daily doses: This increases side effects without improving absorption 1
2. Don't switch between different oral iron salts for intolerance: No evidence supports this practice; instead try alternate-day dosing or parenteral iron 1
3. Don't use modified-release preparations: These are less suitable for prescribing 1
4. Don't rely on blood transfusion alone: Each unit contains only ~200 mg elemental iron, insufficient to replenish stores; always follow with iron replacement 1

Alternative Oral Options

If traditional iron salts fail:

• Ferric maltol (30 mg twice daily): Better tolerated in patients with inflammatory conditions, normalizes hemoglobin in 63-66% at 12 weeks, though more expensive than traditional salts 1
• Alternate-day dosing: Increases fractional iron absorption and reduces gastrointestinal side effects (relative risk 0.56 for GI adverse events) 1

Transfusion Criteria

Reserve packed red cell transfusion only for severe symptomatic anemia with circulatory compromise. 1 Target hemoglobin of 70-90 g/L (80-100 g/L with unstable coronary disease), and always follow with iron replacement therapy as transfusion alone does not replenish iron stores. 1